Chief Financial Officer
William Wagner is a Project Manager for Psy Therapeutics. He works closely with the CEO and CSO to execute Psy’s business planning, budgeting and business development efforts. William also partners with each of Psy’s Target Champions to forecast and implement program plans for each specific project.
Prior to joining Psy, William interned for X-Chem Inc., a Boston-based biopharmaceutical company and a Psy collaborator. While there, he worked on a variety of business development and operations projects, gaining first-hand startup experience which he actively draws upon at Psy. Previously, he worked as a stock analyst at a Boston-based wealth management firm and on the mitigation team for the Conservation Fund in Washington, DC.
William received a BS in Psychology from Trinity College in May 2018.